MESO-Rx

Don Hooton, of the Taylor Hooton Foundation and Dr. Michael Scally, M.D., of HPT/Axis Inc., are both urging the medical community to recognize the condition of Anabolic Steroid Induced Hypogonadism (ASIH) and move towards the acceptance of a medical treatment for hypogonadism after androgen cessation. The recent A&E documentary about Jose Canseco’s decision to stop using anabolic steroids has highlighted the problem of androgen induced hypogonadism that can occur after the discontinuation of anabolic steroids.

Dr. Michael Scally has been a long-time critic of the medical establishment’s failure to address the adverse side effects of hypogonadism in steroid users. He is troubled by the lack of medical initiatives seeking to eliminate, shorten, or minimize the period of anabolic-steroid induced hypogonadism. Dr. Scally released a statement expressing his concern about Jose Canseco’s unsuccessful attempts to find effective treatment for ASIH in response to the A&E special on Canseco. Read more